Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

Nicola Personeni; Laura Giordano; Giovanni Abbadessa; Camillo Porta; Ivan Borbath; Bruno Daniele; Jean Luc Van Laethem; Hans Van Vlierberghe; Jörg Trojan; Enrico N De Toni; Antonio Gasbarrini; Monica Lencioni; Maria E Lamar; Yunxia Wang; Dale Shuster; Brian Schwartz; Armando Santoro; Lorenza Rimassa

doi:10.18632/oncotarget.14797

Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

Nicola Personeni^*
, Laura Giordano
, Giovanni Abbadessa
, Camillo Porta
, Ivan Borbath
, Bruno Daniele
, Jean Luc Van Laethem
, Hans Van Vlierberghe
, Jörg Trojan
, Enrico N De Toni
, Antonio Gasbarrini
, Monica Lencioni
, Maria E Lamar
, Yunxia Wang
, Dale Shuster
, Brian Schwartz
, Armando Santoro
, Lorenza Rimassa

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

14 Citazioni (Scopus)

Abstract

n/a

Lingua originale	Inglese
pagine (da-a)	N/A-N/A
Rivista	Oncotarget
Numero di pubblicazione	jan
DOI	https://doi.org/10.18632/oncotarget.14797
Stato di pubblicazione	Pubblicato - 2017

All Science Journal Classification (ASJC) codes

Oncologia

Keywords

MET
hepatocellular carcinoma
neutrophil-to-lymphocyte ratio
neutrophils
tivantinib

Accesso al documento

10.18632/oncotarget.14797

Altri file e collegamenti

Cita questo

Personeni, N., Giordano, L., Abbadessa, G., Porta, C., Borbath, I., Daniele, B., Van Laethem, J. L., Van Vlierberghe, H., Trojan, J., De Toni, E. N., Gasbarrini, A., Lencioni, M., Lamar, M. E., Wang, Y., Shuster, D., Schwartz, B., Santoro, A., & Rimassa, L. (2017). Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma. Oncotarget, (jan), N/A-N/A. https://doi.org/10.18632/oncotarget.14797

@article{1379a26e0d7d4bb58523c203e676bb60,

title = "Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma",

abstract = "n/a",

keywords = "MET, hepatocellular carcinoma, neutrophil-to-lymphocyte ratio, neutrophils, tivantinib, MET, hepatocellular carcinoma, neutrophil-to-lymphocyte ratio, neutrophils, tivantinib",

author = "Nicola Personeni and Laura Giordano and Giovanni Abbadessa and Camillo Porta and Ivan Borbath and Bruno Daniele and \{Van Laethem\}, \{Jean Luc\} and \{Van Vlierberghe\}, Hans and J{\"o}rg Trojan and \{De Toni\}, \{Enrico N\} and Antonio Gasbarrini and Monica Lencioni and Lamar, \{Maria E\} and Yunxia Wang and Dale Shuster and Brian Schwartz and Armando Santoro and Lorenza Rimassa",

year = "2017",

doi = "10.18632/oncotarget.14797",

language = "English",

pages = "N/A--N/A",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "jan",

}

Personeni, N, Giordano, L, Abbadessa, G, Porta, C, Borbath, I, Daniele, B, Van Laethem, JL, Van Vlierberghe, H, Trojan, J, De Toni, EN, Gasbarrini, A, Lencioni, M, Lamar, ME, Wang, Y, Shuster, D, Schwartz, B, Santoro, A & Rimassa, L 2017, 'Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma', Oncotarget, n. jan, pagg. N/A-N/A. https://doi.org/10.18632/oncotarget.14797

TY - JOUR

T1 - Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

AU - Personeni, Nicola

AU - Giordano, Laura

AU - Abbadessa, Giovanni

AU - Porta, Camillo

AU - Borbath, Ivan

AU - Daniele, Bruno

AU - Van Laethem, Jean Luc

AU - Van Vlierberghe, Hans

AU - Trojan, Jörg

AU - De Toni, Enrico N

AU - Gasbarrini, Antonio

AU - Lencioni, Monica

AU - Lamar, Maria E

AU - Wang, Yunxia

AU - Shuster, Dale

AU - Schwartz, Brian

AU - Santoro, Armando

AU - Rimassa, Lorenza

PY - 2017

Y1 - 2017

N2 - n/a

AB - n/a

KW - MET

KW - hepatocellular carcinoma

KW - neutrophil-to-lymphocyte ratio

KW - neutrophils

KW - tivantinib

KW - MET

KW - hepatocellular carcinoma

KW - neutrophil-to-lymphocyte ratio

KW - neutrophils

KW - tivantinib

UR - https://publicatt.unicatt.it/handle/10807/92729

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85014092751&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85014092751&origin=inward

U2 - 10.18632/oncotarget.14797

DO - 10.18632/oncotarget.14797

M3 - Article

SN - 1949-2553

SP - N/A-N/A

JO - Oncotarget

JF - Oncotarget

IS - jan

ER -

Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo